RSCM
Rock Springs Capital Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $50.6M | Sell |
1,391,072
-3,362
| -0.2% | -$122K | 3.15% | 6 |
|
|
2025
Q1 | $50.5M | Sell |
1,394,434
-345,379
| -20% | -$12.5M | 2.89% | 8 |
|
|
2024
Q4 | $73.2M | Sell |
1,739,813
-238,459
| -12% | -$10M | 2.79% | 9 |
|
|
2024
Q3 | $110M | Buy |
1,978,272
+54,200
| +3% | +$3.01M | 3.58% | 5 |
|
|
2024
Q2 | $79.1M | Buy |
1,924,072
+149,134
| +8% | +$6.13M | 2.38% | 8 |
|
|
2024
Q1 | $82.9M | Buy |
1,774,938
+20,900
| +1% | +$976K | 2.1% | 12 |
|
|
2023
Q4 | $83.9M | Buy |
1,754,038
+277,597
| +19% | +$13.3M | 2.06% | 15 |
|
|
2023
Q3 | $52.6M | Buy |
1,476,441
+92,172
| +7% | +$3.29M | 1.41% | 25 |
|
|
2023
Q2 | $63.9M | Buy |
1,384,269
+47,868
| +4% | +$2.21M | 1.52% | 23 |
|
|
2023
Q1 | $53.6M | Buy |
1,336,401
+46,122
| +4% | +$1.85M | 1.28% | 28 |
|
|
2022
Q4 | $59.8M | Buy |
1,290,279
+102,287
| +9% | +$4.74M | 1.44% | 24 |
|
|
2022
Q3 | $49.2M | Buy |
1,187,992
+94,962
| +9% | +$3.93M | 1.27% | 24 |
|
|
2022
Q2 | $65.2M | Buy |
1,093,030
+64,921
| +6% | +$3.87M | 1.9% | 11 |
|
|
2022
Q1 | $74.7M | Buy |
1,028,109
+144,188
| +16% | +$10.5M | 1.88% | 16 |
|
|
2021
Q4 | $74.3M | Buy |
883,921
+82,812
| +10% | +$6.96M | 1.72% | 16 |
|
|
2021
Q3 | $72.3M | Buy |
801,109
+336,109
| +72% | +$30.3M | 1.52% | 20 |
|
|
2021
Q2 | $44.3M | Buy |
465,000
+15,000
| +3% | +$1.43M | 0.88% | 34 |
|
|
2021
Q1 | $51.2M | Sell |
450,000
-116,500
| -21% | -$13.3M | 1.12% | 29 |
|
|
2020
Q4 | $78.4M | Sell |
566,500
-10,341
| -2% | -$1.43M | 1.66% | 14 |
|
|
2020
Q3 | $47.4M | Sell |
576,841
-70,000
| -11% | -$5.75M | 1.2% | 29 |
|
|
2020
Q2 | $50.6M | Sell |
646,841
-100,959
| -14% | -$7.9M | 1.39% | 19 |
|
|
2020
Q1 | $33.2M | Buy |
747,800
+47,800
| +7% | +$2.12M | 1.37% | 25 |
|
|
2019
Q4 | $29.9M | Buy |
700,000
+92,000
| +15% | +$3.93M | 0.94% | 42 |
|
|
2019
Q3 | $26M | Buy |
608,000
+28,000
| +5% | +$1.2M | 1.04% | 31 |
|
|
2019
Q2 | $36.8M | Hold |
580,000
| – | – | 1.33% | 21 |
|
|
2019
Q1 | $40.2M | Buy |
580,000
+155,000
| +36% | +$10.8M | 1.55% | 11 |
|
|
2018
Q4 | $18.5M | Buy |
425,000
+225,000
| +113% | +$9.78M | 0.87% | 35 |
|
|
2018
Q3 | $15.3M | Hold |
200,000
| – | – | 0.55% | 63 |
|
|
2018
Q2 | $15.4M | Buy |
200,000
+27,000
| +16% | +$2.08M | 0.59% | 65 |
|
|
2018
Q1 | $8.82M | Buy |
173,000
+10,000
| +6% | +$510K | 0.38% | 87 |
|
|
2017
Q4 | $7.56M | Hold |
163,000
| – | – | 0.34% | 87 |
|
|
2017
Q3 | $8.68M | Buy |
163,000
+2,500
| +2% | +$133K | 0.4% | 80 |
|
|
2017
Q2 | $9.97M | Buy |
160,500
+750
| +0.5% | +$46.6K | 0.5% | 62 |
|
|
2017
Q1 | $10.8M | Hold |
159,750
| – | – | 0.62% | 53 |
|
|
2016
Q4 | $11.2M | Buy |
159,750
+12,750
| +9% | +$896K | 0.75% | 44 |
|
|
2016
Q3 | $10.4M | Buy |
147,000
+5,500
| +4% | +$390K | 0.65% | 52 |
|
|
2016
Q2 | $6.92M | Buy |
141,500
+23,000
| +19% | +$1.12M | 0.51% | 61 |
|
|
2016
Q1 | $7.5M | Buy |
118,500
+13,000
| +12% | +$823K | 0.63% | 50 |
|
|
2015
Q4 | $11.8M | Sell |
105,500
-1,500
| -1% | -$168K | 0.9% | 37 |
|
|
2015
Q3 | $10.3M | Buy |
107,000
+15,000
| +16% | +$1.44M | 0.84% | 40 |
|
|
2015
Q2 | $9.42M | Hold |
92,000
| – | – | 0.69% | 50 |
|
|
2015
Q1 | $5.71M | Buy |
92,000
+21,000
| +30% | +$1.3M | 0.53% | 68 |
|
|
2014
Q4 | $3.12M | Buy |
71,000
+3,500
| +5% | +$154K | 0.36% | 78 |
|
|
2014
Q3 | $3.82M | Buy |
67,500
+2,000
| +3% | +$113K | 0.59% | 52 |
|
|
2014
Q2 | $2.94M | Buy |
65,500
+14,000
| +27% | +$628K | 0.53% | 65 |
|
|
2014
Q1 | $2.52M | Buy |
+51,500
| New | +$2.52M | 0.58% | 54 |
|